Attentional Control
MACBRAIN
Developing a Multi-scale Account of Attentional Control as the Constraining Interface Between Vision and Action (MAC-Brain).
2 other identifiers
interventional
76
1 country
1
Brief Summary
The project is dedicated to understanding the integration within the brain of signals of different natures that contribute to attentional control. The investigator will make use of standardized experimental displays involving the discrimination of a target (tilted-bar) presented together with 3 distractor items, with one stimulus in each visual quadrant. Across three fMRI experiments in healthy participants, the investigator will manipulate different types of signals that will guide the subject's attention towards one of the four quadrants: Exp 1 - task instruction \& item salience; Exp 2 - probabilistic target location; Exp 3 - probabilistic reward. The investigator expects that irrespective of the nature of the control signal, activity in dorsal parietal cortex will index the currently relevant/attended location. Moreover, The investigator expects that upon changes of the most relevant location, one will observe activation of the ventral parietal cortex, plus increased inter-regional connectivity between ventral and dorsal parietal regions - again irrespective of the nature of the attention guiding signals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2019
CompletedFirst Posted
Study publicly available on registry
March 13, 2019
CompletedStudy Start
First participant enrolled
July 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2021
CompletedJanuary 11, 2022
January 1, 2022
Same day
March 8, 2019
January 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of hemodynamic response in dorsal parietal regions representing specific spatial locations (visual quadrants)
After spatial pre-processing of individual series of functional magnetic resonance imaging (fMRI) scans, normalization and smoothing as suggested for Statistical Parametric Mapping (SPM) analysis, the different attentional conditions will be modeled and convolved with canonical Hemodynamic Response Function (HRF). The model will be estimated according to the algorithm of SPM. Using a Region of Interest (ROI) approach, the investigator will extract the signal in dorsal parietal regions representing the four visual quadrants, and will compare activity as a function of the attended / most relevant location. The main hypothesis will be confirmed by activation of the ROI corresponding to the currently attended location, irrespective of the nature of the signal guiding attention (i.e. common effects in Exp 1-3).
Day 0
Secondary Outcomes (2)
Evaluation of the brain hemodynamic response
Day 0
Evaluation of the connectivity of the ventral parietal cortex at the time when there is a change of the most relevant spatial location/visual quadrant. x²
Day 0
Study Arms (1)
Attentional Control
EXPERIMENTALVisuo-spatial attentional tasks with simple stimuli during functional magnetic resonance imaging (fMRI) scanning.
Interventions
During the functional magnetic resonance imaging (fMRI) protocol, the subject will perform the attentional task while whole-brain activity will be recorded using Echo Planar Imaging (EPI) that measures the Blood Oxygen Level Dependent (BOLD) signal (2x2x2 isotropic voxels, Echo Time (ET) = 30 ms, Repetition Time (RT) = 2.5 sec). The functional session will be subdivided into several parts ("Runs", duration: 10-15 min). Together with the functional data, the protocol will include a structural scan (T1 weighted, 1x1x1 mm voxels; duration 5-7 min) and a field mapping sequence (duration: 1 min).
Eligibility Criteria
You may qualify if:
- Be 18 to 40 years old
You may not qualify if:
- Previous neurologic or psychiatric disease.
- Cognitive deficits restricting understanding of the tasks.
- Pregnant or breath-feeding women.
- Persons under guardianship, curator or any other administrative or judicial measure of deprivation of rights or liberty.
- Subjects currently participating in other study.
- Neurologic, cardiac electrostimulation or defibrillator.
- Cardiac prostheses
- Intracranial clips or clamps
- Cerebrospinal fluid disorders
- Metal particles in the eyes
- Metal dental or articular prostheses
- Diffusion pomp or other infusion system
- Claustrophobia
- Head tattoo, make-up, hair gel
- Have any copper intrauterine device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inserm U1028 Equipe Impact
Bron, 69676, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emiliano Macaluso, Prof.
INSERM U1028 - Equipe ImpAct CRNL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2019
First Posted
March 13, 2019
Study Start
July 5, 2019
Primary Completion
July 5, 2019
Study Completion
June 21, 2021
Last Updated
January 11, 2022
Record last verified: 2022-01